Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsThe PHOTON study involves more than 42,000 from Indonesia in a five-year multinational clinical trial testing how specific nutritional supplements can interrupt the cycle between undernutrition and active TB.
A health worker examines a woman’s eyes on Aug. 24, 2026, during a free tuberculosis screening and health check in Palembang, South Sumatra. A new clinical trial that started in October 2026, involving tens of thousands of Indonesians, is testing for ways to improve interventions, just as a new TB vaccine is currently being developed. (Antara/Nova Wahyudi)
joint Indonesia-Tanzania clinical trial is testing whether targeted nutritional supplements can prevent tuberculosis (TB) among people exposed to the disease at home, as the country with the world's second-highest TB burden puts more than 42,000 of its own citizens at the center of a potential breakthrough.
Launched in October 2026, the Prevention of Household Tuberculosis with Optimal Nutrition (PHOTON) study involves 78,400 individuals, more than 42,000 from Indonesia and the remainder from Tanzania, in a five-year clinical trial testing how specific nutritional supplements can interrupt the cycle between undernutrition and active TB.
The study was presented on Nov. 11 at the "State of TB Innovation" expert media briefing organized by the Gates Foundation, held online ahead of the International Union Against Tuberculosis and Lung Disease's World Conference on Lung Health, scheduled for Nov. 17-20 in Rio de Janeiro, Brazil.
The World Health Organization (WHO) released its Global TB Report 2026 on Nov. 12.
TB remains the world's deadliest infectious disease, killing approximately 1.13 million people in 2025, according to the WHO Global TB Report 2026. Around 10.6 million people developed the disease that year, of whom an estimated 2.2 million were never diagnosed or reported. The global incidence rate fell by only 1.6 percent, far slower than what experts say is needed to meet international commitments to end TB.
Indonesia accounts for approximately 10 percent of global TB cases, ranking second only to India's 25 percent share, according to the report.
With an estimated 1.08 million cases in 2024, or 382 cases per 100,000 population, Indonesia faces an enormous gap between its current trajectory and its stated goal of eliminating TB by 2030, defined as reducing the incidence rate to 65 cases per 100,000.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.